| Gene symbol | DLL3 | Synonyms | SCDO1 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | delta like canonical Notch ligand 3 | ||||
| GTO ID | GTC3305 |
| Trial ID | NCT05680922 |
| Disease | Lung Small Cell Carcinoma | Large Cell Neuroendocrine Carcinoma |
| Altered gene | DLL3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LB2102 |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer |
| Year | 2023 |
| Country | United States |
| Company sponsor | Legend Biotech USA Inc |
| Other ID(s) | LB2102-1001 |
| Cohort 1 | |||||||||
|
|||||||||